Company / Total Assets
Mineralys Therapeutics, Inc. Total Assets History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$205.9M
FY2024
5-year range
$114.4M / $251.6M
FY2022-FY2024
Trend
-18.2%
vs FY2023
Sector context
#197 of 214
Health Care
What the data says
Among 214 Health Care companies, Mineralys Therapeutics, Inc. is in the bottom 8% for total assets. Improved from $114M to $206M over the past 2 years.
Based on SEC 10-K filings.
$206M in FY2024.
Improved from $114M to $206M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 214This company $205.9M Sector average $7.5B
▼
-97.2% below sector average
Key checks
Key Insights
- In FY2024, total assets decreased 18.2% year-over-year.
- Ranks #197 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $205.9M | -18.2% |
| FY2023 | $251.6M | +119.9% |
| FY2022 | $114.4M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026